402
Participants
Start Date
Not specified
Study Completion Date
January 31, 2006
lopinavir/ritonavir
emtricitabine
stavudine
tenofovir DF
Beth Israel Med. Ctr., ACTU, New York
NY Univ. HIV/AIDS CRS, New York
Univ. of Rochester ACTG CRS, Rochester
Hosp. of the Univ. of Pennsylvania CRS, Philadelphia
IHV Baltimore Treatment CRS, Baltimore
Johns Hopkins Adult AIDS CRS, Baltimore
Unc Aids Crs, Chapel Hill
Univ. of Miami AIDS CRS, Miami
Vanderbilt Therapeutics CRS, Nashville
University of Colorado Hospital CRS, Aurora
Ucsd, Avrc Crs, San Diego
University of Washington AIDS CRS, Seattle
USC CRS, Los Angeles
Univ. of California Davis Med. Ctr., ACTU, Sacramento
SSTAR, Family Healthcare Ctr., Fall River
Wake County Health and Human Services CRS, Raleigh
The Ohio State Univ. AIDS CRS, Columbus
Wits HIV CRS, Johannesburg
Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu
Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis
University of Minnesota, ACTU, Minneapolis
AIDS Care CRS, Rochester
McCree McCuller Wellness Ctr. at the Connection, Infectious Disease Unit, Rochester
Regional Center for Infectious Disease, Wendover Medical Center CRS, Greensboro
Univ. of Cincinnati CRS, Cincinnati
MetroHealth CRS, Cleveland
Pitt CRS, Pittsburgh
The Miriam Hosp. ACTG CRS, Providence
Puerto Rico-AIDS CRS, San Juan
National Institute of Allergy and Infectious Diseases (NIAID)
NIH